Invention Grant
- Patent Title: Topical formulation for a JAK inhibitor
-
Application No.: US17704180Application Date: 2022-03-25
-
Publication No.: US11590136B2Publication Date: 2023-02-28
- Inventor: Bhavnish Parikh , Bhavesh Shah , Krishnaswamy Yeleswaram
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington; US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington; US DE Wilmington
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P17/06
Abstract:
This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.
Public/Granted literature
- US20220378792A1 TOPICAL FORMULATION FOR A JAK INHIBITOR Public/Granted day:2022-12-01
Information query
IPC分类:
